[{"Assets_0_Q3_USD":447738000.0,"CommonStockSharesOutstanding_0_Q3_shares":30994005.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-36750000.0,"NetIncomeLoss_1_Q3_USD":-17847000.0,"NetIncomeLoss_3_Q3_USD":-89944000.0,"StockholdersEquity_0_Q3_USD":198097000.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20191106"}]